Loading clinical trials...
Loading clinical trials...
Liquid Biopsy as a Biomarker in Patients Treated With PSMA Radioligand Therapy
Conditions
Locations
3
Germany
University hospital Wuerzburg - Department of Nuclear Medicine
Augsburg, Germany
TUM Klinikum rechts der Isar - Department of Nuclear medicine
München, Germany
University hospital Wuerzburg - Department of Nuclear Medicine
Würzburg, Germany
Start Date
September 1, 2024
Primary Completion Date
December 1, 2026
Completion Date
August 1, 2028
Last Updated
August 12, 2025
NCT07177937
NCT06594926
NCT06844383
NCT06926283
NCT06487507
NCT05919264
Lead Sponsor
Wuerzburg University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions